Veradigm (NASDAQ:MDRX) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX) in a research report report published on Tuesday. The firm issued a hold rating on the software maker’s stock.

MDRX has been the subject of a number of other research reports. Barclays initiated coverage on Veradigm in a research note on Wednesday, January 3rd. They issued an equal weight rating and a $11.00 target price for the company. Royal Bank of Canada reduced their price objective on Veradigm from $22.00 to $11.00 and set an outperform rating for the company in a research note on Friday, January 19th. Finally, Deutsche Bank Aktiengesellschaft reiterated a hold rating and set a $10.00 price objective (down previously from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Veradigm currently has an average rating of Hold and a consensus price target of $11.25.

Veradigm Stock Performance

Shares of MDRX stock opened at $7.96 on Tuesday. The business has a fifty day moving average of $7.75 and a 200 day moving average of $9.92. Veradigm has a 1 year low of $5.01 and a 1 year high of $14.09.

Institutional Investors Weigh In On Veradigm

A number of institutional investors have recently modified their holdings of MDRX. Wellington Management Group LLP boosted its holdings in Veradigm by 117.8% in the 4th quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock worth $60,908,000 after buying an additional 3,140,483 shares during the last quarter. Pacer Advisors Inc. lifted its stake in Veradigm by 108.1% in the 4th quarter. Pacer Advisors Inc. now owns 2,516,574 shares of the software maker’s stock worth $26,399,000 after purchasing an additional 1,307,024 shares in the last quarter. William Blair Investment Management LLC lifted its stake in Veradigm by 16.6% in the 3rd quarter. William Blair Investment Management LLC now owns 4,375,005 shares of the software maker’s stock worth $57,488,000 after purchasing an additional 623,438 shares in the last quarter. Kent Lake Capital LLC lifted its stake in Veradigm by 62.2% in the 4th quarter. Kent Lake Capital LLC now owns 1,500,000 shares of the software maker’s stock worth $15,735,000 after purchasing an additional 575,000 shares in the last quarter. Finally, Creative Planning lifted its stake in Veradigm by 2,848.4% in the 3rd quarter. Creative Planning now owns 474,376 shares of the software maker’s stock worth $6,233,000 after purchasing an additional 458,287 shares in the last quarter.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.